EUVIMEDEUVIMED entdecken
Open Access

Cancer and benign tumors in myotonic dystrophy, facioscapulohumeral muscular dystrophy, and oculopharyngeal muscular dystrophy: a 23-year, single-center, retrospective study.

Naman Bareja, Brinda Desai, Michal Vytopil, Jayashri Srinivasan, Mehdi Ghasemi

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · 01.06.2025 · 44 (2) · 49-56

DOI: 10.36185/2532-1900-997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, erschienen am 01.06.2025. Verfasst von Naman Bareja und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tufts Medical Center, Boston, MA, USA. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Muscular Dystrophy, Facioscapulohumeral, Neoplasms, Muscular Dystrophy, Oculopharyngeal. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Some muscular dystrophies, such as myotonic dystrophy type 1 and 2 (DM1 and DM2), facioscapulohumeral muscular dystrophy (FSHD), and oculopharyngeal muscular dystrophy (OPMD), are caused by genetic mutations that may affect the expression and function of various cancer-related genes. We assessed the frequency and type of cancers and benign tumors in patients with DM1, DM2, FSHD, and OPMD.

Methods

We conducted a single-center, retrospective, cross-sectional study on patients with DM1, DM2, FSHD, and OPMD at our institution from January 2000 to September 2023.

Results

Seventy seven (46 female) DM1, 20 (15 female) DM2, 40 (18 female) FSHD, and 46 (22 female) OPMD patients were included, among which 22 (28.57%), 9 (45%), 7 (17.5%), and 15 (32.61%) patients had at least one cancer, respectively. Median age (range) of patients where presence or absence of cancer was ascertained was 65 (18-87), 63.5 (45-86), 61 (27-83), and 71.5 (40-82) years, respectively (P < 0.0001). Overall, non-sex-related cancers were more frequent than sex-related cancers among all patients together. Independent to sex and age, DM1 patients had an increased risk of non-sex-related cancers compared to non-DM cases. Melanoma (P < 0.01) and testicular (P < 0.05) cancers were significantly more frequent in DM2 and OMPD patients, respectively. DM patients had also increased risk of non-sex related benign tumors (including skin and thyroid benign tumors) compared to non-DM patients.

Conclusions

Our study highlights the differences in the prevalence of cancers and benign tumors among patients with DM1, DM2, FSHD, and OPMD, underscoring the potential need for regular screening for specific cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyMuscular Dystrophy, FacioscapulohumeralNeoplasmsMuscular Dystrophy, OculopharyngealHumansMaleFemaleRetrospective StudiesMiddle AgedCross-Sectional StudiesAdultAgedYoung Adult

Stichwörter der Autor:innen

Myotonic dystrophycancerfacioscapulohumeral muscular dystrophy (FSHD)melanomaoculopharyngeal muscular dystrophy (OPMD)thyroid tumor

Autor:innen und Institutionen

  • Department of Neurology, Tufts Medical Center, Boston, MA, USA.
  • Department of Neurology, Lahey Hospital and Medical Center, Burlington, MA, USA.

Zitieren

APA

Bareja, N., Desai, B., Vytopil, M., Srinivasan, J., & Ghasemi, M. (2025). Cancer and benign tumors in myotonic dystrophy, facioscapulohumeral muscular dystrophy, and oculopharyngeal muscular dystrophy: a 23-year, single-center, retrospective study. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, 44(2), 49-56. https://doi.org/10.36185/2532-1900-997

Vancouver

Bareja N, Desai B, Vytopil M, Srinivasan J, Ghasemi M. Cancer and benign tumors in myotonic dystrophy, facioscapulohumeral muscular dystrophy, and oculopharyngeal muscular dystrophy: a 23-year, single-center, retrospective study. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases. 2025;44(2):49-56. doi:10.36185/2532-1900-997

BibTeX
@article{Bareja2025,
  author = {Bareja, Naman and Desai, Brinda and Vytopil, Michal and Srinivasan, Jayashri and Ghasemi, Mehdi},
  title = {Cancer and benign tumors in myotonic dystrophy, facioscapulohumeral muscular dystrophy, and oculopharyngeal muscular dystrophy: a 23-year, single-center, retrospective study},
  journal = {Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases},
  year = {2025},
  volume = {44},
  number = {2},
  pages = {49--56},
  doi = {10.36185/2532-1900-997}
}
Kostenlos starten →